The combination of placenta-derived stem cells (PMSCs) with standard in utero repair for severe spina bifida appears feasible and safe, with no cell-related adverse events observed at birth, a ...

A rare group of neurons can reconnect broken spinal circuits and trigger leg muscle activity after spinal cord injury—a discovery that could help refine future stem-cell therapies for paralysis. The ...

A Phase I clinical trial led by researchers at University of California San Diego School of Medicine has demonstrated the long-term safety and feasibility of neural stem cell transplantation for ...

A phase 1 clinical trial demonstrated the long-term safety and feasibility of neural stem cell transplantation for treating chronic spinal cord injuries. The corresponding study was published in Cell ...

January 27, 2009 — Geron Corp announced it has received US Food and Drug Administration (FDA) approval for a phase 1 trial of GRNOPC1, a cell therapy derived from human embryonic stem cells (hESC), in ...

A phase I clinical trial led by researchers at University of California San Diego School of Medicine has demonstrated the long-term safety and feasibility of neural stem cell transplantation for ...

Add Yahoo as a preferred source to see more of our stories on Google. A University of Minnesota Twin Cities research team has combined 3D printing, stem cell biology, and lab-grown tissues to address ...

Amyotrophic lateral sclerosis (ALS) is a fast-progressing neurodegenerative disease with an average survival time of three years and no effective treatments. In ALS, motor neurons in the spinal cord, ...

Prof. Tal Dvir, Head of the Sagol Center for Regenerative Biotechnology, Head of the Nanotechnology Center at Tel Aviv University, and Chief Scientist of the biotech company Matricelf. The surgery is ...

Amyotrophic lateral sclerosis (ALS) is a fast-progressing neurodegenerative disease with an average survival time of three years and no effective treatments. In ALS, motor neurons in the spinal cord, ...